Associations Between COVID-19 and Hospitalisation with Respiratory and Non-Respiratory Conditions: A Record Linkage Study

Associations Between COVID-19 and Hospitalisation with Respiratory and Non-Respiratory Conditions: A Record Linkage Study

Published: Nov 14, 2022
Publisher: The Medical Journal of Australia (online ahead of print)
Download
Authors

Stacey L. Rowe

Karin Leder

Kylie Dyson

Lalitha Sundaresan

Dennis Wollersheim

Brigid Lynch

Ifrah Abdullahi

Benjamin C. Cowie

Nicola Stephens

Terence M. Nolan

Sheena G. Sullivan

Brett Sutton

Allen C. Cheng

Objectives

To assess associations between SARS-CoV-2 infection and the incidence of hospitalisation with selected respiratory and non-respiratory conditions in a largely SARS-CoV-2 vaccine-naïve population.

Design, setting, participants

Self-control case series; analysis of population-wide surveillance and administrative data for all laboratory-confirmed COVID-19 cases notified to the Victorian Department of Health (onset, 23 January 2020 – 31 May 2021; ie, prior to widespread vaccination rollout) and linked hospital admissions data (admission dates to 30 September 2021).

Main outcome measures

Hospitalisation of people with acute COVID-19; incidence rate ratios (IRRs) comparing incidence of hospitalisations with defined conditions (including cardiac, cerebrovascular, venous thrombo-embolic, coagulative, and renal disorders) from three days before to within 89 days of onset of COVID-19 with incidence during baseline period (60–365 days prior to COVID-19 onset).

Results

A total of 20 594 COVID-19 cases were notified; 2992 people (14.5%) were hospitalised with COVID-19. The incidence of hospitalisation within 89 days of onset of COVID-19 was higher than during the baseline period for several conditions, including myocarditis and pericarditis (IRR, 14.8; 95% CI, 3.2–68.3), thrombocytopenia (IRR, 7.4; 95% CI, 4.4–12.5), pulmonary embolism (IRR, 6.4; 95% CI, 3.6–11.4), acute myocardial infarction (IRR, 3.9; 95% CI, 2.6–5.8), and cerebral infarction (IRR, 2.3; 95% CI, 1.4–3.9).

Conclusion

SARS-CoV-2 infection is associated with higher incidence of hospitalisation with several respiratory and non-respiratory conditions. Our findings reinforce the value of COVID-19 mitigation measures such as vaccination, and awareness of these associations should assist the clinical management of people with histories of SARS-CoV-2 infection.

How do you apply evidence?

Take our quick four-question survey to help us curate evidence and insights that serve you.

Take our survey